Please login to the form below

Not currently logged in
Email:
Password:

Antares appoints David Bergstrom as SVP

Second major appointment in one month

Antares Pharma has appointed Dr David Bergstrom as senior VP of pharmaceutical development.

Dr Bergstrom joins from Advantar Laboratories where he serves as executive VP and chief operating officer.

His previous roles included spells as chief operating office of NoveDel Pharmaceuticals and general manager of pharmaceutical development at Cardinal Health.

He is the second senior VP to join Antares this month after the appointment of former Pfizer VP Dr Bruce Freundlich as senior VP, medical.

The appointments come as the company looks to expand its business after the commercialisation of Otrexup (methotrexate) for arthritis and the advance in development of testosterone replacement therapy Vibex QS T.

Dr Paul Wotton, CEO of Antares, said: "David has a proven track record as a leader of product development teams and has worked on multiple FDA approved products including 505B2 drug/device combination programmes. His broad product development expertise will help drive our pipeline initiative."

20th November 2013

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics